# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124698
Filing Date
2024-11-12
Accepted
2024-11-12 08:56:48
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | hrtx-20240930.htm iXBRL | 10-Q | 1571250
2 | EX-10.1 | hrtx-ex10_1.htm | EX-10.1 | 31073
3 | EX-10.2 | hrtx-ex10_2.htm | EX-10.2 | 21211
4 | EX-31.1 | hrtx-ex31_1.htm | EX-31.1 | 15958
5 | EX-31.2 | hrtx-ex31_2.htm | EX-31.2 | 15765
6 | EX-32.1 | hrtx-ex32_1.htm | EX-32.1 | 16801
| Complete submission text file | 0000950170-24-124698.txt |  | 7171685

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20240930.xsd | EX-101.SCH | 933806
64 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20240930_htm.xml | XML | 1339504

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 241443892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)